Summary
The relative bioavailabilities of single oral doses of ampicillin, amoxycillin, and bacampicillin were compared with and without concomitant administration of a six-times higher molar dose of cyclacillin. As the absorption of cyclacillin has been shown to involve a capacity-limited transport system in animals, it was selected as the reference compound for the study. The treatments were given to 14 fasting volunteers using a randomized, complete crossover design. The drugs in plasma and urine were determined by liquid chromatography. Renal clearance was 17%, 10% and 19% lower when ampicillin, amoxycillin, and bacampicillin were given together with cyclacillin. Consequently, differences in the relative bioavailability were based on urinary recoveries assuming constant non-renal clearance. When amoxycillin was given with cyclacillin there was a 67% delay in the time of the plasma peak concentration, and an 8% lower urinary recovery than when it was given alone. There was a 50% and 33% delay in the tmax of ampicillin and bacampicillin when combined with cyclacillin; the urinary recovery of ampicillin in the combination was 10% lower but that of bacampicillin was similar. There was also a 20% delay in the tmax of cyclacillin when combined with amoxycillin. The differences in renal clearance indicate an interaction in the renal elimination of the drugs, but the effect was probably not the explanation for the marked shift in time of the absorption of these rapidly absorbed drugs. The results support the existence of a capacity-limited transport system for aminopenicillins in the human gut.
Similar content being viewed by others
References
Carlqvist J, Westerlund D (1985) Automated determination of amoxycillin in biological fluids by column-switching in ion-pair RPLC systems with post-column derivatization. J Chromatogr (in press)
Chiou WL (1978) Critical evaluation of the potential error in pharmacokinetic studies of using the linear trapezoidal rule method for the calculation of the area under the plasma-level time curve. J Pharmacokinet Biopharm 6: 539–546
Conover WJ, Iman RL (1981) Rank transformations as a bridge between parametric and nonparametric statistics. Am Stat 35: 124–129
Doyle FP, Nayler JHC (1964) Penicillins and related structures. In: Harper NJ, Simmonds AB (eds) Advances in drug research, vol 1. Academic Press, London, pp 8–13
Friedrich M (1982) Fortschrittsbericht. Die intestinale Phase der Peptidabsorption. Nahrung 26: 887–901
Gibaldi M, Perrier D (1982) Pharmacokinetics. Marcel Dekker, New York
Hertz CG (1973) Serum and urinary concentrations of cyclacillin in humans. Antimicrob Agents Chemother 4: 361–365
Hwang S, Kwan KC (1980) Further considerations on model-independent bioavailability estimation. J Pharm Sci 69: 77–80
Kimura T, Endo H, Yoshikawa M, Muranishi S, Sezaki H (1978) Carrier-mediated transport systems for aminopenicillins in rat small intestine. J Pharmacobiodyn 1: 262–267
Magni L, Sjövall J, Syvälahti E (1978) Comparative clinical pharmacology of bacampicillin and high oral doses of ampicillin. Infection 6: 283–289
Matthews DM (1975) Intestinal transport of peptides. In: Csáky TZ (ed) Intestinal absorption and malabsorption. Raven Press, New York, pp 95–111
Miyazaki K, Ogino O, Nakano M, Arita T (1977) Intestinal absorption mechanisms of ampicillin derivatives in rats. I. Intestinal absorption of ampicillin derivatives. Chem Pharm Bull 25: 246–252
Nakashima E, Tsuji A, Mizuo H, Yamana T (1984) Kinetics and mechanism of in vitro uptake of amino-β-lactam antibiotics by rat small intestine and relation to the intact-peptide transport system. Biochem Pharmacol 33: 3345–3352
Physicians' desk reference, 38th edition (1984), Angel JE (ed). Oradell NJ Medical Economics Company, pp 2138
Shindo H, Fukuda K, Kawai K, Tanaka K (1978) Studies on intestinal absorption of pivampicillin and species difference in the intestinal esterase activity. J Pharmacobiodyn 1: 310–323
Silk DBA (1982) Disorders of nitrogen absorption. Clin Gastroenterol 11: 47–72
Sjövall J, Alván G, Westerlund D (1985a) Dose-dependent absorption of amoxycillin and barampicillin. Clin Pharmacol Ther 38: 241–250
Sjövall J, Magni L, Bergan T (1978) Pharmacokinetics of bacampicillin compared to those of ampicillin, pivampicillin, and amoxycillin. Antimicrob Agents Chemother 13: 90–96
Sjövall J, Westerlund D, Alván G (1985b) Renal excretion of intravenously infused amoxycillin and ampicillin. Br J Clin Pharmacol 19: 191–201
Tsuji A, Nakashima E, Kagami I, Yamana T (1981a) Intestinal absorption mechanism of amphoteric β-lactam antibiotics I: Comparative absorption and evidence for saturable transport of amino-β-lactam antibiotics by in situ rat small intestine. J Pharm Sci 70: 768–772
Tsuji A, Nakashima E, Kagami I, Yamana T (1981b) Intestinal absorption mechanism of amphoteric β-lactam antibiotics II: Michaelis-Menten kinetics of cyclacillin absorption and its pharmacokinetic analysis in rats. J Pharm Sci 70: 772–777
Tsuji A, Yamana T (1981) Gastrointestinal absorption of β-lactam antibiotics. In: Mitsuhashi, Susumu (eds), Beta-lactam antibiotics. Jpn Sci Soc Press, Tokyo, Japan, pp 235–258 (English)
Westerlund D, Carlqvist J, Theodorsen A (1979) Analysis of penicillins in biological material by reversed-phase liquid chromatography and post-column derivatization. Acta Pharm Suec 16: 187–214
Winer BJ (1962) Statistical principles in experimental design. McGraw-Hill, New York
Yamaoka K, Nakagawa T, Uno T (1978) Statistical moments in pharmacokinetics. J Pharmacokinet Biopharm 6: 547–558
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sjövall, J., Alván, G. & Westerlund, D. Oral cyclacillin interacts with the absorption of oral ampicillin, amoxycillin, and bacampicillin. Eur J Clin Pharmacol 29, 495–502 (1985). https://doi.org/10.1007/BF00613468
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00613468